InterMune Know IPF Now

InterMune Know IPF Now

Lung transplantation and clinical trials

Lung transplantation

  • A lung transplant may be an option for some patients with idiopathic pulmonary fibrosis (IPF) who meet certain criteria. A lung transplant has the potential to extend lifespan. However, there are risks involved with this procedure, including serious complications from infections and rejection of the lung.

Your doctor may have you evaluated for transplantation after you are diagnosed. Talk to your doctor to see if you’re a candidate for lung transplantation.

Learn more

Clinical trials and the future of IPF

Clinical trials are studies in which people volunteer to test the latest medicines or procedures that experts think might improve the treatment of IPF. Different clinical trials have different requirements and risks, and you must meet certain requirements to participate in a clinical trial.

Your doctor will determine if you are eligible to be in the study. There are no guarantees about the safety or success of participating in a study. There is a chance that unexpected side effects could occur, or that the study treatment may not work as well as hoped. If you are interested in participating in a trial, you and your doctors will talk about these and other possible risks.

Learn more about clinical trials.

Find answers to your questions about IPF